CN106138569A - A kind of Chinese medicine composition treating chronic wound and application thereof - Google Patents

A kind of Chinese medicine composition treating chronic wound and application thereof Download PDF

Info

Publication number
CN106138569A
CN106138569A CN201610651331.0A CN201610651331A CN106138569A CN 106138569 A CN106138569 A CN 106138569A CN 201610651331 A CN201610651331 A CN 201610651331A CN 106138569 A CN106138569 A CN 106138569A
Authority
CN
China
Prior art keywords
chinese medicine
parts
medicine composition
chronic wound
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201610651331.0A
Other languages
Chinese (zh)
Other versions
CN106138569B (en
Inventor
白妮
徐建文
陈赟
方旭晨
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHANGHAI YANGPU SHIDONG HOSPITAL
Original Assignee
SHANGHAI YANGPU SHIDONG HOSPITAL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHANGHAI YANGPU SHIDONG HOSPITAL filed Critical SHANGHAI YANGPU SHIDONG HOSPITAL
Priority to CN201610651331.0A priority Critical patent/CN106138569B/en
Publication of CN106138569A publication Critical patent/CN106138569A/en
Application granted granted Critical
Publication of CN106138569B publication Critical patent/CN106138569B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/889Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/55Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/286Carthamus (distaff thistle)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/32Burseraceae (Frankincense family)
    • A61K36/324Boswellia, e.g. frankincense
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/32Burseraceae (Frankincense family)
    • A61K36/328Commiphora, e.g. mecca myrrh or balm of Gilead
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to technical field of traditional Chinese medicine, be specifically related to a kind of Chinese medicine composition treating chronic wound and application thereof.The Chinese medicine composition of the treatment chronic wound of the present invention, in parts by weight, comprises following crude drug: Sanguis Draxonis 20 30 parts, 10 30 parts of Flos Carthami, Olibanum 5 10 parts, Myrrha 5 10 parts, 0.1 0.3 parts of Moschus, Borneolum Syntheticum 25 parts.The present invention is with Sanguis Draxonis as monarch drug, and Flos Carthami is ministerial drug, and Olibanum, Myrrha are adjuvant drug, and Moschus, Borneolum Syntheticum are for making medicine.The pathomechanism occur for chronic wound, be in progress, healed, uses Traditional Chinese medicine blood circulation promoting blood stasis dispelling, removing the necrotic tissue and promoting granulation, sore to combine.The theory of doctor trained in Western medicine moisture treatment, proves through clinical practice, treats all kinds of chronic wound.

Description

A kind of Chinese medicine composition treating chronic wound and application thereof
Technical field
The present invention relates to technical field of traditional Chinese medicine, be specifically related to a kind of Chinese medicine composition treating chronic wound and answer With.
Background technology
Chronic wound is also referred to as skin ulcer, refractory wound surface, refers to that any failing has according to normal wound healing process The wound healed within the scheduled time to sequence;The wound surface failing more than 3 months to heal can become chronic wound.
Chronic wound there may be the several years and do not heals even all the life, causes psychology and physical stress that patient is serious, and thus Huge financial burden is brought to patient and whole health care system.
Along with aged tendency of population, body weight increases and increasing is secondary to the disease such as diabetes, impaired function of vein Sick complication, chronic wound sufferer number significantly increases.According to statistics, the people of about 1% at it in life it may happen that leg Ulcer., the most just there is the cost nearly 50-100 hundred million dollars of 300-600 ten thousand chronic wound these wound surface of patient treatment in the only U.S.. In China, according to epidemiological study result, in inpatients in surgical department, the ratio of chronic wound is about 1.5% to 20.3%.
In recent years, the patient of various chronic diseases increases year by year, causes associated pressure ulcer, diabetic foot, lower limb quiet Also there is high incidence in the chronic wounds such as arteries and veins ulcer.As a example by diabetic foot, recent five years, world's onset diabetes rate is annual With the surprising speed increment of 11%.The most existing suffer from diabetes close to 200,000,000 people, and it is the fifth-largest that the most therefore diabetes become the world The cause of the death.By the estimation of IDF (IDF), current diabetes mellitus in China patient has reached fifty-five million people, annual new discovery sugar Urine patient 120 people, and increase with the speed of people's every day at least 3000.In following 3 years to 5 years, these diabetes patients Middle the patient having 15% can suffer from diabetic foot, serious will face amputation.
Additionally, along with the continuous aging of population, the sickness rate of venous leg ulcers and pressure ulcer rises constantly.
Although chronic wound will not life-threatening immediately, but because of up to even several years several months, the more than ten years are prolonged does not heals, seriously Affect patient's protopathy rehabilitation and quality of life, also bring heavy nursing and financial burden to family.Minority can occur ulcer Canceration.If occurring to infect diffusion, may result in the complication such as sepsis, not only increasing the weight of protopathy but also threat to life.
Chronic wound is different from general traumatic surface, and its traumatic condition is increasingly complex.No matter pathogenesis, site of pathological change or The aspects such as antibacterial infection conditions, Pathologic changes, have different epidemiology and pathological characteristic, and wound repair method is the most not to the utmost Identical.Its cause of disease many bad with traumatic infection, locally blood supply, diabetes, radioactivity are relevant.So fundamentally to cure or to control System carries out Comprehensive Treatment within normal range.
The treatment of chronic wound relates to many such as the department of Chinese medicine, Dept. of Hyperbaric Oxygen, department of general surgery, orthopaedics, department of dermatologry, department of endocrinology Section, the method for the treatment of divides No operation and operative treatment.Non-operative treatment includes: topical agent;Various dressing;Various naturopathy Means (sound, light, heat, electricity etc.);Vacuum suction;Guan Bi vacuum suction;Somatomedin;Also can be by hyperbaric oxygentherapy.Operation side Method includes: debridement and suturing;Skin-grafting;Big foreign body skin covers;Various local or axial skin flap;Microsurgery tissue transplantation;Neural, Blood vessel, the micro suture of tendon and transplanting etc..
Over the past thousands of years, the Chinese medicine external of motherland's medical science but has the curative effect of uniqueness to wound healing.External application Chinese medicine is promoted The use mechanism of wound healing, the traditional Chinese medical science has saying of " removing the necrotic tissue and promoting granulation being snuggled up to pus and put on flesh ", and existing research shows, external application Chinese medicine can promote Wound surface secretion a large amount of consistence things, i.e. " pus ".In wound healing mid-term, this " pus " liquid is the most, then wound healing is the fastest, this and doctor trained in Western medicine In moisture treatment play the same tune on different musical instruments part.Thus, the active ingredient of application modern science and technology prize external Chinese medicament purifies, and Figuration, in new pattern compress, plays a role jointly, promotes the healing of wound surface further.
Summary of the invention
It is an object of the invention to overcome the deficiencies in the prior art, it is provided that a kind of Chinese medicine composition treating chronic wound And application.The present invention is with Sanguis Draxonis as monarch drug, and Flos Carthami is ministerial drug, and Olibanum, Myrrha are adjuvant drug, and Moschus, Borneolum Syntheticum are for making medicine.For slowly Property the wound surface pathomechanism that occurs, be in progress, heal, use Traditional Chinese medicine blood circulation promoting blood stasis dispelling, removing the necrotic tissue and promoting granulation, sore to combine.The moist treatment of doctor trained in Western medicine The theory of method, proves through clinical practice, treats all kinds of chronic wound.
The purpose of the present invention is achieved through the following technical solutions:
The first object of the present invention is to provide a kind of Chinese medicine composition treating chronic wound, in parts by weight, comprises Following crude drug: Sanguis Draxonis 20-30 part, Flos Carthami 10-30 part, Olibanum 5-10 part, Myrrha 5-10 part, Moschus 0.1-0.3 part, Borneolum Syntheticum 2- 5 parts.
Further, described Chinese medicine composition, in parts by weight, comprise following crude drug: Sanguis Draxonis 30 parts, 20 parts of Flos Carthami, Olibanum 10 parts, Myrrha 10 parts, 0.2 part of Moschus, Borneolum Syntheticum 2 parts.
Further, described Chinese medicine composition can be made into oil immersion liquid, hydrocolloid or contains drug solns.
Further, the preparation method of described oil immersion liquid is as follows: weighting raw materials, takes 1500ml olive oil and is heated to 120 DEG C-150 DEG C put into Flos Carthami, keep this temperature, treat that Flos Carthami is decocted to sallow, filter, retain filtrate;Insert Olibanum, Myrrha, stir cold But to 50 DEG C-80 DEG C, insert Sanguis Draxonis, Moschus, Borneolum Syntheticum, stir natural cooling, place 24 hours and filter standby.
Further, the preparation method of described hydrocolloid is as follows: weighting raw materials, with liquid-solid extraction method from crude drug Extract original liquid, using 60vol% ethanol as Extraction solvent, 1.5 hours extraction times, Extracting temperature 60 DEG C, solid-liquid ratio 1:30, Extract to obtain original liquid, then original liquid is mixed by weight 30-45:100 with Carboxymethyl cellulose sodium, pectin or gelatin, system Standby one-tenth water soluble hydrocolloids.
Further, the described preparation method containing drug solns is as follows: extract former medicine from crude drug with liquid-solid extraction method Liquid, using ethanol as Extraction solvent, 1.5 hours extraction times, Extracting temperature 60 DEG C, volume fraction of ethanol 60%, crude drug with Weight ratio 1:30 of ethanol, extracts to obtain original liquid, then is arranged to containing concentration be the pharmaceutical extraction of 30-45wt% with sterilized water Thing solution.
The second object of the present invention is to provide above-mentioned Chinese medicine composition in preparation treatment treatment chronic wound medicine Application.
Further, after described Chinese medicine composition being made oil immersion liquid, hydrocolloid or containing drug solns, infiltrate or be coated on algae Hydrochlorate fabric, is prepared as pastille dressing.
Each crude drug Action Specification in Chinese medicine composition of the present invention is as follows:
Sanguis Draxonis: babassu, the resin in the brown fruit of kylin and rattan.Nature and flavor: sweet, salty, flat, GUIXIN, liver spleen channel.Merit Effect: promoting blood circulation to remove blood stasis, analgesic therapy for oral administration, external hemostasia and promoting granulation, sore.Sanguis Draxonis water logging agent (1:2) is to trichophyton, the most blue achorion, Austria Du big belly little spore tinea bacterium, rust little spore tinea bacterium, ulotrichy little spore tinea bacterium, epidermophyton inguinale, color bead-containing bacteria, star Shape slave blocks the dermatophytess such as bacterium all inhibitory action in various degree.Also having report to point out, Sanguis Draxonis is to staphylococcus aureus, lemon Lemon color staphylococcus, Nai Shi coccus, diphtheria corynebacterium and Bacillus typhi have the strongest bacteriostasis.To escherichia coli, bacillus pyocyaneus, Shigella flexneris etc. have stronger bacteriostasis.Sanguis Draxonis also has antiinflammatory action, and suppression platelet aggregation accelerates platelet electricity Swimming speed, still has significant anti thrombotic action.But clotting time, prothrombin time and blood viscosity are had no significant effect.Join not Medicine, Olibanum, the power of its promoting blood circulation and breaking stagnation strengthens, blood activating and promoting tissue regeneration sore again, therefore can be used for malignant boil, carbuncle, do not close up for a long time, gold is created Blood, wound such as do not conform at the disease.
Flos Carthami: Flos Carthami is Compositae platymiscium, has another name called Flos Carthami, red Cymbidium ensifolium (L.) Sw. etc., 1 year or biennial herb.Warm in nature, return The heart, liver two, gas perfume (or spice) row dissipates, enters blood system.Have invigorate blood circulation, blood stasis dispelling, analgesic efficacy.
Olibanum: for olive subject plant.The oleo-gum-resin that the skin zones such as Boswellia carterii, Bao Da Boswellia carterii, wild Boswellia carterii ooze out, taste Pungent, bitter, slightly warm in nature, GUIXIN, liver, spleen channel.Effect: blood-activating and qi-promoting, inducing menstruation to relieve menalgia, detumescence and promoting granulation, cures mainly traumatic injury stasis of blood pain, and carbuncle swells Poison, the sore being festered and unhealed.
Myrrha: for olive subject plant.If the oleo-gum-resin that loblolly tree and congener trunk skin zone ooze out, bitter in the mouth, property are flat, return Liver, spleen, the heart, kidney channel.Effect: promoting blood circulation and stopping pain, detumescence and promoting granulation, cures mainly carbuncle skin infection.
Moschus: for animal in deer family.Woods Moschus moschiferous, horse Moschus moschiferous or the dry secretions of former Moschus moschiferous maturation hero body adenocele.Acrid in the mouth, property Temperature, GUIXIN, liver, spleen channel.Effect: refreshment of having one's ideas straightened out, promoting blood circulation to restore menstrual flow, removing obstruction for relieving pain, its pungent perfume (or spice) of property walks to alter, and outer and skin hair key is without institute Do not reach.
Borneolum Syntheticum: for Dipterocarpaceae aiphyllium plant, the processed finished products of Borneolum Syntheticum resin or the trunk of Borneolum Syntheticum through distillation Crystallize obtained by cooling, claim " borneol ".By the sublimate of Compositae perennial herb thing thing Herba Blumeae Balsamiferae (great Ai) processed split cut and Become, claim " Blumeae preparatum Tabellae ".Existing multiplex Oleum Terebinthinae, Camphora etc., through being chemically synthesized, claim " BORNEOLUM SYNTHETICUM ".Acrid in the mouth is bitter, cool in nature, GUIXIN Warp, Xin Xiang walks to alter, and pungent scattered bitter pond, is use with Moschus mutual reinforcement between, and the two one high one delays, reducing swelling and alleviating pain, and has the antipruritic effect of anticorrosion, clear Thermal detoxification, erosion prevention and muscle growing.
The present invention is directed to generation and the healing mechanism of chronic wound, through clinical practice for many years, it is believed that chronic wound because of Stagnation of QI-blood heresy poison enters flesh, blood circulation promoting and blood stasis dispelling in treatment, promoting tissue regeneration and ulcer healing after first removing the necrotic tissue.Select Chinese medicine for this present invention, extract through science Take active ingredient and be prepared as hydrocolloid, replenisher, and figuration on alginate fabric, direct external application or fill wound surface, the most effectively Rate reaches 86%, evident in efficacy.
Accompanying drawing explanation
Fig. 1 is the therapeutic process wound surface picture of case one;Wherein, before a is for treatment, after b is for treating February;
Fig. 2 is the therapeutic process wound surface picture of case two;Wherein, before a is for treatment, after b is for treating February;
Fig. 3 is the therapeutic process wound surface picture of case three;Wherein, a is that wound surface opens wide, and b is with containing the former medicine attached type of oil immersion liquid Wound is filled in dressing;C is for add interruption vacuum suction continued treatment containing former medicine oil immersion liquid dressing.
Detailed description of the invention
Below in conjunction with specific embodiment, the present invention is expanded on further.Should be understood that these embodiments are merely to illustrate the present invention Rather than restriction the scope of the present invention.
Embodiment 1 treats Chinese medicine composition and the preparation thereof of chronic wound
A kind of Chinese medicine composition treating chronic wound, in parts by weight, comprises following crude drug: Sanguis Draxonis 30 parts, Flos Carthami 20 parts, Olibanum 10 parts, Myrrha 10 parts, 0.2 part of Moschus, Borneolum Syntheticum 2 parts.
Above-mentioned Chinese medicine composition is prepared as respectively oil immersion liquid, hydrocolloid or contains drug solns:
1, the preparation of oil immersion liquid: weighting raw materials, 1500ml olive oil is put and is heated to 120 DEG C-150 DEG C in copper pot and puts into red Flower, keeps this temperature, treats that Flos Carthami is decocted to sallow, filters and inserts Olibanum, Myrrha, and stirring is cooled to 50 DEG C-80 DEG C, insert Sanguis Draxonis, Moschus, Borneolum Syntheticum, stir natural cooling, places 24 hours and filters standby.
2, the preparation of hydrocolloid: weighting raw materials, extracts original liquid with liquid-solid extraction method from crude drug.Extract after deliberation Take optimum condition: select ethanol as Extraction solvent, 1.5 hours extraction times, Extracting temperature 60 DEG C, volume fraction of ethanol 60%, solid-liquid ratio 1:30, extract to obtain original liquid, then by original liquid with Carboxymethyl cellulose sodium, pectin or gelatin by weight 30-45:100 mixes, and is prepared as water soluble hydrocolloids.
3, the preparation containing drug solns (replenisher) extracts original liquid with liquid-solid extraction method from crude drug.Extract after deliberation Optimum condition: select ethanol as Extraction solvent, 1.5 hours extraction times, Extracting temperature 60 DEG C, volume fraction of ethanol 60%, Solid-liquid ratio 1:30, extracts to obtain original liquid, and the pharmaceutical extraction thing being then arranged to containing concentration is 30-45wt% with sterilized water is molten Liquid.
Embodiment 2 treats the clinical application effect evaluation of the Chinese medicine composition of chronic wound
The dressing using embodiment 1 preparation carries out clinical treatment, is described as follows:
1, case selection
All cases are selected from January, 2012 to my gate emergency treatment, inpatient, totally 100 example of in December, 2015, divide at random Become treatment group and each 50 examples of matched group.Male 31 examples for the treatment of group, female 19 example, age 49-88 year, average 68.2 years old;Wherein, severe cranium Brain injury 7 example, cerebral infarction 15 example, cerebral hemorrhage 8 example, respiratory failure 2 example, heart failure 3 example, high paraplegia 2 example, complication with diabetes 29 examples.Inclusion criteria: failed more than 3 months healing wound surface, wherein pressure ulcer 52 example (treatment group 28 example, matched group 24 example), under Limb venous ulcer 11 example (treatment group 7 example, matched group 4 example).Diabetic ulcer 21 example (treatment group 9 example, matched group 12 example), Reason the brightest wound surface 16 example (treatment group 6 example, matched group 10 example).Left card side inspection respectively in terms of age, sex, the state of an illness between two groups Test, no significant difference (P 0.05), between two groups, there is comparability.
2. Therapeutic Method:
2.1 treatment groups: patient uses oil immersion liquid dressing, hydrocolloid prepared by embodiment 1 or composes containing drug solns (replenisher) The alginate fabric dressing external application wound surface of shape, is spaced replacing in 1-2 days.
2.2 persistently close in negative pressure treatment at wound surface, with Chinese medicine composition extract solution (the i.e. pastille containing embodiment 1 Solution) retain every day and rinse secondary.
2.3 matched groups: clean after wound surface with 1:5000 furacilin solution, then with sterile vaseline gauze and other dressing Wrapping, cleans and changes once, do efficacy evaluation after 8 weeks for 1-2 days.
3. curative effect determinate standard
The People's Republic of China's traditional Chinese medicine industry standard issued with reference to State Administration of Traditional Chinese Medicine " examine by surgery of Chinese medicine disease Disconnected criterion of therapeutical effect ", Ministry of Public Health " new Chinese medicine clinical research guide " formulate curative effect grade scale.
Recovery from illness: wound surface heals completely, clinical symptom disappearance, follows up a case by regular visits to 2 months without recurrence.
Effective: wound surface area reduces and reaches more than 70%, and clinical symptoms disappears substantially.
Take a turn for the better: wound surface area reduces and reaches more than 30%, and clinical symptoms is improved.
Invalid: wound surface area reduces less than 30% or unchanged or expansion, and clinical symptoms is without improving.
4. therapeutic effect: two groups of patients after curative treatment compare and are shown in Table 1
Two groups of patients after curative treatment compare (table 1)
Note: P 0.05 compared with matched group
Two groups of comparitive study, treatment group cure rate, total effective rate are substantially better than matched group, have comparability, P 0.05.
In above-mentioned case, pick out 3 model cases and describe in detail
Case one: Lee XX, women, 78 years old.After cerebral hemorrhage, paralysis bed more than 2 years, the huge decubital ulcer of left side hip, go deep into bone Bone face.Fig. 1 a is the wound surface before treatment, and Fig. 1 b is the wound surface after treating February, it will be seen from figure 1 that wound healing is effective.
Case two: XX male Cai, 72 years old, parkinson, lie in bed 3 years, left ischial tuberosity portion decubital ulcer more than a year, the VI phase. Fig. 2 a is the wound surface before treatment, and Fig. 2 b is the wound surface after treating February, figure it is seen that through bimestrial treatment, wound surface Fully recover, do not recur so far.
Case three: Shen XX, male, 64 years old, patient 2007.11.28 was because of " aching pain in waist and back companion's left lower extremity is numb " morbidity two weeks Being admitted to hospital, MRI points out Spinal canal encroachment, and 2007.12.03 detects at general anesthesia descending T6-8 laminectomy for decompression, canalis spinalis, Intraspinal neoplasm Enucleation.Postoperative there is incontinence of urination and defecation, and abdominal reflex exist, and right side stomach wall feels to drop to umbilical plane, under left side stomach wall sensation Dropping to groin, anus has light contraction function.
Post operative diagnosis: 1, intramedullary spinal tumor is postoperative 2, below T6 paraplegia
2008.02.02 leaving hospital, 2008.02.18 is admitted to hospital again, finds " right leg outer side has size about 2*2cm pressure ulcer ".
Diameter 3cm decubital ulcer seen from hip on the right side of in the of 2009.12, wound surface is the most dry clean.
On the right side of in the of 2010.10, buttocks has diameter 6cm pressure ulcer, and wound surface oozes out on a small quantity, and granulation tissue is the freshest.
Having diameter 8cm pressure ulcer on the right side of in the of 2011.12 outside buttocks, wound surface oozes out on a small quantity, and granulation tissue owes fresh.
Being respectively arranged with diameter 9cm pressure ulcer on the right side of in the of 2013.01 outside buttocks, wound surface oozes out on a small quantity, and granulation tissue owes fresh.
2014.03.18 the descending right hip decubitus wound debridement of general anesthesia.
2014.03.25,39.5 DEG C of high heat occur, opens wide (such as Fig. 3 a) through wound surface, strengthen negative pressure drainage, hyperpyrexia.
2014.03.29 to fill wound (such as Fig. 3 b) containing the attached type dressing of former medicine oil immersion liquid, use and be interrupted punching containing drug solns Wash, high febrile lysis.After with containing former medicine oil immersion liquid add interruption vacuum suction continued treatment (such as Fig. 3 c).
2015.06.18 patient leaves hospital automatically.While in hospital occurs without high heat again.
Below preferred embodiment to the invention is illustrated, but the invention is not limited to described Embodiment, those of ordinary skill in the art also can make all equivalents on the premise of the invention spirit Modification or replacement, modification or the replacement of these equivalents are all contained in the application claim limited range.

Claims (8)

1. treat a Chinese medicine composition for chronic wound, in parts by weight, comprise following crude drug: Sanguis Draxonis 20-30 part, Flos Carthami 10-30 part, Olibanum 5-10 part, Myrrha 5-10 part, Moschus 0.1-0.3 part, Borneolum Syntheticum 2-5 part.
A kind of Chinese medicine composition treating chronic wound the most according to claim 1, it is characterised in that: described Chinese medicine composition Thing, in parts by weight, comprises following crude drug: Sanguis Draxonis 30 parts, 20 parts of Flos Carthami, Olibanum 10 parts, Myrrha 10 parts, 0.2 part of Moschus, ice Sheet 2 parts.
A kind of Chinese medicine composition treating chronic wound the most according to claim 1, it is characterised in that: described Chinese medicine composition Thing can be made into oil immersion liquid, hydrocolloid or contains drug solns.
A kind of Chinese medicine composition treating chronic wound the most according to claim 3, it is characterised in that: described oil immersion liquid Preparation method is as follows: weighting raw materials, takes 1500ml olive oil and is heated to 120 DEG C-150 DEG C and puts into Flos Carthami, keeps this temperature, treat Flos Carthami is decocted to sallow, filters, and retains filtrate, inserts Olibanum, Myrrha, and stirring is cooled to 50 DEG C-80 DEG C, inserts Sanguis Draxonis, Moschus, ice Sheet, stirs natural cooling, places 24 hours and filters standby.
A kind of Chinese medicine composition treating chronic wound the most according to claim 3, it is characterised in that: described hydrocolloid Preparation method is as follows: weighting raw materials, extracts original liquid with liquid-solid extraction method from crude drug, using ethanol as Extraction solvent, 1.5 hours extraction times, Extracting temperature 60 DEG C, volume fraction of ethanol 60%, crude drug and weight ratio 1:30 of ethanol, extract Original liquid, then mixes original liquid by weight 30-45:100 with Carboxymethyl cellulose sodium, pectin or gelatin, is prepared as water Dissolubility hydrocolloid.
A kind of Chinese medicine composition treating chronic wound the most according to claim 3, it is characterised in that: described containing drug solns Preparation method as follows: from crude drug, extract original liquid with liquid-solid extraction method, using ethanol as Extraction solvent, extraction time 1.5 hours, Extracting temperature 60 DEG C, volume fraction of ethanol 60%, crude drug and weight ratio 1:30 of ethanol, extract to obtain original liquid, Then it is arranged to containing the pharmaceutical extraction thing solution that concentration is 30-45wt% with sterilized water.
7. according to the answering in preparation treatment treatment chronic wound medicine of the Chinese medicine composition described in any one of claim 1-6 With.
Application the most according to claim 7, it is characterised in that: described Chinese medicine composition is made oil immersion liquid, hydrocolloid or After drug solns, infiltrate or be coated on alginate fabric, being prepared as pastille dressing.
CN201610651331.0A 2016-08-10 2016-08-10 Traditional Chinese medicine composition for treating chronic wound and application thereof Expired - Fee Related CN106138569B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610651331.0A CN106138569B (en) 2016-08-10 2016-08-10 Traditional Chinese medicine composition for treating chronic wound and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610651331.0A CN106138569B (en) 2016-08-10 2016-08-10 Traditional Chinese medicine composition for treating chronic wound and application thereof

Publications (2)

Publication Number Publication Date
CN106138569A true CN106138569A (en) 2016-11-23
CN106138569B CN106138569B (en) 2020-07-31

Family

ID=57329496

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610651331.0A Expired - Fee Related CN106138569B (en) 2016-08-10 2016-08-10 Traditional Chinese medicine composition for treating chronic wound and application thereof

Country Status (1)

Country Link
CN (1) CN106138569B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107349335A (en) * 2017-06-13 2017-11-17 吉林省拓华生物科技有限公司 One kind carries medicine membrane film and its production and use
CN109010570A (en) * 2018-09-03 2018-12-18 李宗涛 A kind of band bed sore ointment for treating bedsore
CN112274562A (en) * 2020-12-01 2021-01-29 闫恪玉 Formula for relieving swelling and pain

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1439413A (en) * 2003-03-26 2003-09-03 彭德生 Chinese medicine against skin and external diseases
CN101112480A (en) * 2007-08-15 2008-01-30 关瑞峰 Golden powder for treating wound
CN101428122A (en) * 2008-12-10 2009-05-13 李金梅 Traditional Chinese medicine powder for removing necrotic tissue and promoting granulation and preparation method thereof
CN101791364A (en) * 2010-04-28 2010-08-04 董崇孝 Traditional Chinese medicine composition capable of promoting wound healing and preparation method thereof
CN102240354A (en) * 2011-06-20 2011-11-16 张佑强 Chinese medicine prescription for treating skin ulcer and preparation method thereof
CN104721445A (en) * 2015-04-01 2015-06-24 张金学 Traditional Chinese medicine ointment for treating bedsores and preparation method thereof

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1439413A (en) * 2003-03-26 2003-09-03 彭德生 Chinese medicine against skin and external diseases
CN101112480A (en) * 2007-08-15 2008-01-30 关瑞峰 Golden powder for treating wound
CN101428122A (en) * 2008-12-10 2009-05-13 李金梅 Traditional Chinese medicine powder for removing necrotic tissue and promoting granulation and preparation method thereof
CN101791364A (en) * 2010-04-28 2010-08-04 董崇孝 Traditional Chinese medicine composition capable of promoting wound healing and preparation method thereof
CN102240354A (en) * 2011-06-20 2011-11-16 张佑强 Chinese medicine prescription for treating skin ulcer and preparation method thereof
CN104721445A (en) * 2015-04-01 2015-06-24 张金学 Traditional Chinese medicine ointment for treating bedsores and preparation method thereof

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107349335A (en) * 2017-06-13 2017-11-17 吉林省拓华生物科技有限公司 One kind carries medicine membrane film and its production and use
CN109010570A (en) * 2018-09-03 2018-12-18 李宗涛 A kind of band bed sore ointment for treating bedsore
CN112274562A (en) * 2020-12-01 2021-01-29 闫恪玉 Formula for relieving swelling and pain

Also Published As

Publication number Publication date
CN106138569B (en) 2020-07-31

Similar Documents

Publication Publication Date Title
US11571452B2 (en) Method of treating a skin wound with a liquid-state topical pharmaceutical composition
CN100448473C (en) A Chinese traditional externally use medicinal composition for treatment of diabetic feet
CN102091203B (en) External traditional Chinese medicine preparation for treating chronic wounds and preparation method thereof
CN102125634A (en) Chinese medicinal composition for treating bedsore
CN106138569A (en) A kind of Chinese medicine composition treating chronic wound and application thereof
CN102861287A (en) Chinese medicinal composition for treating damp-heat invasion blood stasis diabetic foot and preparation method thereof
CN103893557A (en) Traditional Chinese medicine preparation for treating bedsore
CN103977113B (en) A kind of Chinese medicine for the treatment of diabetic foot
CN101607067A (en) A kind of Chinese medicine preparation and preparation method for the treatment of cholelithiasis
CN1846749A (en) Groundcherry oral liquid and its prepn process
CN101513478B (en) External application ointment for treating III stage angiitis
CN104623304A (en) Lotion for treating chronic skin ulcer caused by damp-heat and toxicity accumulation and preparation method of lotion
CN104306707A (en) Medicament composition for treating bedsore
CN111110786A (en) Traditional Chinese medicine for treating bedsore trauma and preparation method thereof
CN104306734B (en) Treat diabetic gangrene externally applied ointment preparation and preparation method thereof
CN105327290B (en) A kind of external application Chinese medicine and preparation method thereof for treating diabetic gangrene
CN108992581A (en) A kind of traditional Chinese medicinal ointment and preparation method thereof for treating skin lesion
CN102423419B (en) External traditional Chinese preparation for treating bedsore
CN110403995B (en) Traditional Chinese medicine composition for treating superficial phlebitis and preparation, use methods and application thereof
CN111603537B (en) Traditional Chinese medicine composition and oil agent for treating carbuncle-abscess sores and ulcers and preparation method and application of traditional Chinese medicine composition and oil agent
CN102526413B (en) Bladder care irrigation solution and preparation method thereof
CN102526533A (en) Method for preparing traditional Chinese medicine lotion for treating ecthyma caused by fever
CN105832909A (en) Traditional Chinese medicine preparation for treating necrotic ulcer of skin
CN104825675A (en) Traditional Chinese medicine formula for treating acute/chronic osteomyelitis and preparation method thereof
CN105412417A (en) Traditional Chinese medicine ointment for treating tenosynovitis and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20200731

Termination date: 20210810